Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wu Ke

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Cancer Letters|April 27, 2023
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapyZhao-Ru Dong, Jia-Bin Cai, Guo-Ming Shi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 7, 2014
Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinomaZhao-Ru Dong, Chi Zhang, Jia-Bin Cai, et al.
Journal of Cancer|November 21, 2017
Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A CirrhosisZhao-Ru Dong, Jie Zou, Dong Sun, et al.
Molecular Cancer|May 21, 2020
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axisXiao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, et al.
Molecular Cancer|February 29, 2024
Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axisXiao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2024
Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitorsSi-Wei Wang, Qiu-Yi Zheng, Wei-Feng Hong, et al.
Journal of Cellular Physiology|December 12, 2018
The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5pXuan Yang, Jia-Bin Cai, Rui Peng, et al.
Plos One|October 1, 2011
Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinomaRanjan Prasad Devbhandari, Guo-Ming Shi, Ai-Wu Ke, et al.
Autophagy|June 22, 2011
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosisYing-Hong Shi, Zhen-Bin Ding, Jian Zhou, et al.
Theranostics|March 25, 2020
miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loopDong-Li Liu, Li-Li Lu, Li-Li Dong, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Cancer Letters|April 27, 2023
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapyZhao-Ru Dong, Jia-Bin Cai, Guo-Ming Shi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 7, 2014
Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinomaZhao-Ru Dong, Chi Zhang, Jia-Bin Cai, et al.
Journal of Cancer|November 21, 2017
Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A CirrhosisZhao-Ru Dong, Jie Zou, Dong Sun, et al.
Molecular Cancer|May 21, 2020
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axisXiao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, et al.
Molecular Cancer|February 29, 2024
Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axisXiao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2024
Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitorsSi-Wei Wang, Qiu-Yi Zheng, Wei-Feng Hong, et al.
Journal of Cellular Physiology|December 12, 2018
The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5pXuan Yang, Jia-Bin Cai, Rui Peng, et al.
Plos One|October 1, 2011
Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinomaRanjan Prasad Devbhandari, Guo-Ming Shi, Ai-Wu Ke, et al.
Autophagy|June 22, 2011
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosisYing-Hong Shi, Zhen-Bin Ding, Jian Zhou, et al.
Theranostics|March 25, 2020
miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loopDong-Li Liu, Li-Li Lu, Li-Li Dong, et al.
Pageof 11